Writing Group Disclosures

Writing Group MemberEmploymentResearch GrantOther Research SupportSpeakers’ Bureau/HonorariaExpert WitnessOwnership InterestConsultant/Advisory BoardOther
Deborah Rohm YoungKaiser Permanente Southern CaliforniaNoneNoneNoneNoneNoneNoneNone
Marie-France HivertHarvard Pilgrim Health Care InstituteNoneNoneNoneNoneNoneNoneNone
Sofiya AlhassanUniversity of MassachusettsNoneNoneNoneNoneNoneNoneNone
Sarah M. CamhiUniversity of MassachusettsNoneNoneNoneNoneNoneNoneNone
Jane F. FergusonVanderbilt University Medical CenterNoneNoneNoneNoneNoneNoneNone
Peter T. KatzmarzykPennington Biomedical Research CenterNoneNoneNoneNoneNoneNoneNone
Cora E. LewisUniversity of Alabama at BirminghamNIH*NoneNoneNoneNoneNoneNone
Neville OwenBaker IDI Heart and Diabetes Institute, MelbourneNational Health and Medical Research Council of Australia*NoneNoneNoneNoneNoneNational Health and Medical Research Council of Australia*
Cynthia K. PerryOregon Health & Science UniversityNoneNoneNoneNoneNoneNoneNone
Juned SiddiqueNorthwestern UniversityNoneNoneNoneNoneNoneNoneNone
Celina M. YongStanford UniversityNoneNoneNoneNoneNoneNoneNone
  • This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

  • * Significant.